Skip to content

Clinical trials

Phase 2/3 COVID-19 trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Country / region: South Africa Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20208
202110
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
BioNTech SE2
Merck Sharp & Dohme LLC2
AstraZeneca1
COVID-19 Prevention Network1
Clover Biopharmaceuticals AUS Pty1
Invivyd, Inc.1
Kiniksa Pharmaceuticals International, plc1
NEAT ID Foundation1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1921
Coronavirus Infections4
Pneumonia2
Coronaviridae Infections1
HIV Infections1
Nidovirales Infections1
RNA Virus Infections1
Severe Acute Respiratory Syndrome1
Virus Diseases1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.